BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30594161)

  • 1. Acceptability of option B+ among HIV positive women receiving antenatal and postnatal care services in selected health centre's in Lusaka.
    Chanda BC; Likwa RN; Zgambo J; Tembo L; Jacobs C
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):510. PubMed ID: 30594161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
    DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
    BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of provider-initiated HIV testing as an intervention for prevention of mother to child transmission of HIV and associated factors among pregnant women attending at Public Health Facilities in Assosa town, Northwest Ethiopia.
    Abtew S; Awoke W; Asrat A
    BMC Res Notes; 2015 Nov; 8():661. PubMed ID: 26553035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of PMTCT services and associated factors among pregnant women attending antenatal clinics in Addis Ababa, Ethiopia.
    Deressa W; Seme A; Asefa A; Teshome G; Enqusellassie F
    BMC Pregnancy Childbirth; 2014 Sep; 14():328. PubMed ID: 25234199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one Hospital Lusaka, Zambia.
    Mukosha M; Chiyesu G; Vwalika B
    Pan Afr Med J; 2020; 35():49. PubMed ID: 32537054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of adherence to option B+ approach for the prevention of mother to child transmission of human immunodeficiency virus in Abuja, 2017.
    Dada AO; Abubakar A; Bashorun A; Nguku P; Oladimeji A
    Pan Afr Med J; 2021; 38():54. PubMed ID: 33854683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and opportunities of optimal breastfeeding in the context of HIV option B+ guidelines.
    Marinda P; Chibwe N; Tambo E; Lulanga S; Khayeka-Wandabwa C
    BMC Public Health; 2017 Jun; 17(1):541. PubMed ID: 28578686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia.
    Tarekegn M; Baru A; Seme A
    Sex Reprod Healthc; 2019 Dec; 22():100459. PubMed ID: 31442747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of measures aimed at preventing mother-to-child transmission of HIV among pregnant women.
    Abiodun MO; Ijaiya MA; Aboyeji PA; Balogun OR
    J Natl Med Assoc; 2008 Apr; 100(4):406-10. PubMed ID: 18481479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection.
    Mubiana-Mbewe M; Bosomprah S; Saroj RK; Kadota J; Koyuncu A; Thankian K; Vinikoor MJ
    AIDS Res Ther; 2023 Apr; 20(1):21. PubMed ID: 37024961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
    Ngarina M; Tarimo EA; Naburi H; Kilewo C; Mwanyika-Sando M; Chalamilla G; Biberfeld G; Ekstrom AM
    PLoS One; 2014; 9(1):e85310. PubMed ID: 24465532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive breastfeeding and associated factors among HIV positive mothers in Northern Ethiopia.
    Gejo NG; Weldearegay HG; W/Tinsaie KT; Mekango DE; Woldemichael ES; Buda AS; Dinsa LH; Alemayehu M; Goba G
    PLoS One; 2019; 14(1):e0210782. PubMed ID: 30650156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
    Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
    PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary counselling and testing (VCT) for Human Immunodeficiency Virus: a study on acceptability by Nigerian women attending antenatal clinics.
    Ekanem EE; Gbadegesin A
    Afr J Reprod Health; 2004 Aug; 8(2):91-100. PubMed ID: 15623124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.